{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:02:20Z","timestamp":1794405740046,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010296","name":"Vignan&apos;s Foundation for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vascn.2026.108417","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:38:33Z","timestamp":1771717113000},"page":"108417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["QbD-based, greenness and whiteness-assessed LC\u2013MS\/MS method for simultaneous determination of sodium phenylbutyrate and Taurursodiol with pharmacokinetic application"],"prefix":"10.1016","volume":"138","author":[{"given":"Thirumalavasu","family":"Palla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Kanaka Srivani","family":"Maddala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaraswamy","family":"Gandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/10600280231172802","article-title":"Sodium phenylbutyrate and taurursodiol: A new therapeutic option for the treatment of amyotrophic lateral sclerosis","volume":"58","author":"Alqallaf","year":"2024","journal-title":"The Annals of Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/epj.epj_295_23","article-title":"Development and validation of a stability-indicating analytical method for simultaneous determination of sodium phenylbutyrate and taurursodiol in bulk and formulation using reverse phase ultra-performance liquid chromatography","volume":"23","author":"Beludari","year":"2024","journal-title":"Egyptian Pharmaceutical Journal"},{"issue":"1","key":"10.1016\/j.vascn.2026.108417_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.6059","article-title":"Highly sensitive LC\u2013MS\/MS method for determination of dexamethasone in rat plasma and brain tissue: An application to pharmacokinetic study in rats","volume":"39","author":"Bestha","year":"2025","journal-title":"Biomedical Chromatography"},{"issue":"7","key":"10.1016\/j.vascn.2026.108417_bb0020","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/19440049.2016.1198497","article-title":"Development of high-throughput multi-residue method for non-steroidal anti-inflammatory drugs monitoring in swine muscle by LC-MS\/MS","volume":"33","author":"Castilhos","year":"2016","journal-title":"Food Additives & Contaminants: Part A"},{"issue":"40","key":"10.1016\/j.vascn.2026.108417_bb0025","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.chroma.2010.08.017","article-title":"Multiresidue analysis of sulfonamides in meat by supramolecular solvent microextraction, liquid chromatography and fluorescence detection and method validation according to the 2002\/657\/EC decision","volume":"1217","author":"Costi","year":"2010","journal-title":"Journal of Chromatography. A"},{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17482960802320487","article-title":"Phase 2 study of sodium phenylbutyrate in ALS","volume":"10","author":"Cudkowicz","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"6","key":"10.1016\/j.vascn.2026.108417_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.202400001","article-title":"Quality by design-engineered reversed-phase high-performance liquid chromatography method development and validation for simultaneous estimation of neomycin sulfate and beclomethasone dipropionate in bulk and pharmaceutical dosage form","volume":"7","author":"Dessai","year":"2024","journal-title":"Separation Science Plus"},{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jaoacint\/qsab132","article-title":"Greenness assessment of two validated stability-indicating chromatographic methods for estimating modafinil using the analytical eco-scale","volume":"105","author":"Elsheikh","year":"2022","journal-title":"Journal of AOAC International"},{"key":"10.1016\/j.vascn.2026.108417_bb0045","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous estimation of tadalafil and macitentan in rat plasma: Greenness assessment and design of experiment approach","volume":"3","author":"Gandu","year":"2025","journal-title":"Green Analytical Chemistry"},{"issue":"3","key":"10.1016\/j.vascn.2026.108417_bb0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/22297928.2025.2503448","article-title":"Greenness evaluation and quality by design-driven LC-MS\/MS method for simultaneous estimation of irbesartan and cilnidipine in rat plasma","volume":"15","author":"Gandu","year":"2025","journal-title":"Analytical Chemistry Letters"},{"key":"10.1016\/j.vascn.2026.108417_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.scp.2024.101463","article-title":"Greenness, blueness and whiteness evaluated \u2013 Chemometric approach enhanced by Latin hypercube technique for the analysis of lidocaine, diclofenac and carcinogenic impurity 2,6-dimethylaniline","volume":"38","author":"Halim","year":"2024","journal-title":"Sustainable Chemistry and Pharmacy"},{"key":"10.1016\/j.vascn.2026.108417_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.scp.2023.101201","article-title":"Inclusive study for sustainable enantioseparation of racemic chlorpheniramine and caffeine by HPLC using dual cyclodextrin system as chiral mobile phase additive: Assessment with AGREE and complex-GAPI approaches","volume":"35","author":"Hammouda","year":"2023","journal-title":"Sustainable Chemistry and Pharmacy"},{"key":"10.1016\/j.vascn.2026.108417_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","article-title":"Clinical and experimental applications of sodium phenylbutyrate","volume":"11","author":"Iannitti","year":"2011","journal-title":"Drugs R D"},{"issue":"4","key":"10.1016\/j.vascn.2026.108417_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22301","article-title":"New insights into sodium phenylbutyrate as a pharmacotherapeutic option for neurological disorders","volume":"78","author":"Juarez","year":"2024","journal-title":"Synapse"},{"key":"10.1016\/j.vascn.2026.108417_bb0075","article-title":"Greenness metrics for analytical methodologies linked to mass spectrometry","volume":"3","author":"Jurisch","year":"2024","journal-title":"Green Analytical Chemistry"},{"issue":"7","key":"10.1016\/j.vascn.2026.108417_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40261-024-01371-1","article-title":"Sodium phenylbutyrate and tauroursodeoxycholic acid: A story of hope turned to disappointment in amyotrophic lateral sclerosis treatment","volume":"44","author":"Ketabforoush","year":"2024","journal-title":"Clinical Drug Investigation"},{"issue":"1","key":"10.1016\/j.vascn.2026.108417_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-022-00307-z","article-title":"Tauroursodeoxycholic acid: A potential therapeutic tool in neurodegenerative diseases","volume":"11","author":"Khalaf","year":"2022","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.vascn.2026.108417_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2024.100153","article-title":"Green RP-HPLC method for simultaneous quantification of epigallocatechin-3-gallate and rosmarinic acid in lipid-based nanocarriers and biological fluids: Quality by design-driven optimization and lean six sigma approach","volume":"11","author":"Koli","year":"2024","journal-title":"Green Analytical Chemistry"},{"issue":"8","key":"10.1016\/j.vascn.2026.108417_bb0095","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/pca.3360","article-title":"Robust high-performance thin-layer chromatography (HPTLC) method for stability assessment and simultaneous quantification of epigallocatechin-3-gallate and rosmarinic acid in lipid-based nanoparticles and biological matrices","volume":"36","author":"Koli","year":"2024","journal-title":"Phytochemical Analysis"},{"issue":"9","key":"10.1016\/j.vascn.2026.108417_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.202400105","article-title":"High-performance liquid chromatography\u2013based standardization of stigmasterol in Moringa oleifera: Method development and validation through design of experiment approach","volume":"7","author":"Kunchanur","year":"2024","journal-title":"Separation Science Plus"},{"issue":"4","key":"10.1016\/j.vascn.2026.108417_bb0105","first-page":"345","article-title":"Emerging therapeutic approaches for amyotrophic lateral sclerosis (ALS)","volume":"20","author":"Kushwaha","year":"2024","journal-title":"Iranian Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.vascn.2026.108417_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/22297928.2025.2531321","article-title":"Validated LC-MS\/MS method for a third-generation BCr-Abl1 inhibitor, vodobatinib quantification in rat plasma and brain tissue, and its application to preclinical pharmacokinetics","volume":"15","author":"Madipelli","year":"2025","journal-title":"Analytical Chemistry Letters"},{"issue":"19","key":"10.1016\/j.vascn.2026.108417_bb0115","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chemistry"},{"key":"10.1016\/j.vascn.2026.108417_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2024.100126","article-title":"A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness","volume":"10","author":"Mansour","year":"2024","journal-title":"Green Analytical Chemistry"},{"issue":"1","key":"10.1016\/j.vascn.2026.108417_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/ijms24010440","article-title":"HPLC method validation for the estimation of lignocaine HCl, ketoprofen and hydrocortisone: Greenness analysis using AGREE score","volume":"24","author":"Mehmood","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.vascn.2026.108417_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/21646821.2015.1075181","article-title":"Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: An overview","volume":"55","author":"Morris","year":"2015","journal-title":"Neurodiagnostic Journal"},{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2990.2010.01061.x","article-title":"Neuromuscular synaptic vulnerability in motor neurone disease: Amyotrophic lateral sclerosis and spinal muscular atrophy","volume":"36","author":"Murray","year":"2010","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"2","key":"10.1016\/j.vascn.2026.108417_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.aca.2007.05.029","article-title":"Validation according to European Commission decision 2002\/657\/EC of a confirmatory method for aflatoxin M1 in milk based on immunoaffinity columns and high-performance liquid chromatography with fluorescence detection","volume":"594","author":"Muscarella","year":"2007","journal-title":"Analytica Chimica Acta"},{"issue":"6","key":"10.1016\/j.vascn.2026.108417_bb0145","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.3390\/ijms25063520","article-title":"Disruption of neuromuscular junction following spinal cord injury and motor neuron diseases","volume":"25","author":"Nemeth","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.vascn.2026.108417_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","article-title":"Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis","volume":"133","author":"Nijssen","year":"2017","journal-title":"Acta Neuropathologica"},{"issue":"10","key":"10.1016\/j.vascn.2026.108417_bb0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2026.108417_bb0160","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2147\/PPA.S136754","article-title":"Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: Patient perspectives","volume":"11","author":"Pe\u00f1a-Quintana","year":"2017","journal-title":"Patient Preference and Adherence"},{"key":"10.1016\/j.vascn.2026.108417_bb0165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fnins.2019.00532","article-title":"Motor neuron susceptibility in ALS\/FTD","volume":"13","author":"Ragagnin","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.vascn.2026.108417_bb0170","first-page":"70","article-title":"Validation of a stability-indicating analytical method development for simultaneous estimation of sodium phenylbutyrate and taurursodiol in bulk and formulation using UPLC","volume":"21","author":"Raju","year":"2025","journal-title":"Iranian Journal of Pharmaceutical Sciences"},{"issue":"04","key":"10.1016\/j.vascn.2026.108417_bb0175","first-page":"225","article-title":"Development and validation of an LC-MS\/MS method for pharmacokinetic assessment of tucatinib in rat plasma","volume":"15","author":"Ramarao","year":"2025","journal-title":"Journal of Applied Pharmaceutical Science"},{"issue":"7","key":"10.1016\/j.vascn.2026.108417_bb0180","first-page":"790","article-title":"UV and HPTLC-based approaches towards rutin determination in Abutilon theophrasti extract","volume":"14","author":"Rane","year":"2022","journal-title":"Journal of Pharmaceutical Sciences and Research"},{"key":"10.1016\/j.vascn.2026.108417_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpba.2015.06.030","article-title":"Determination of dihydromyricetin in rat plasma by LC\u2013MS\/MS and its application to a pharmacokinetic study","volume":"114","author":"Tong","year":"2015","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"4","key":"10.1016\/j.vascn.2026.108417_bb0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jpba.2007.07.007","article-title":"LC\u2013MS\/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma","volume":"45","author":"Xu","year":"2007","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.vascn.2026.108417_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101013","article-title":"Green analytical chemistry metrics for evaluating the greenness of analytical procedures","volume":"14","author":"Yin","year":"2024","journal-title":"Journal of Pharmaceutical Analysis"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:56:52Z","timestamp":1775714212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871926000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"alternative-id":["S1056871926000109"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108417","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QbD-based, greenness and whiteness-assessed LC\u2013MS\/MS method for simultaneous determination of sodium phenylbutyrate and Taurursodiol with pharmacokinetic application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108417"}}